Sivelestat is a cell-permeable sulfanilide compound that acts as a potent, substrate-competitive, and highly specific inhibitor of neutrophil elastase (IC50 = 19-49 nM in rat, rabbit, hamster, human, and mouse leukocyte elastase). Sivelestat displays >100-fold greater selectivity over pancreas elastase (IC50 = 5.6 μM). Sivelestat does not inhibit trypsin, thrombin, plasmin, kallikrein, chymotrypsin, and cathepsin G even at concentrations as high as 100 μM. Sivelestat effectively suppresses human neutrophil elastase-induced lung hemorrhage and skin capillary permeability. Sivelestat is also reported to inhibit mast cell Stat6-protease.
1. Suzuki, K., et al. 2003. Biochem. Biophys. Res. Commun. 309, 768. 2. Kawabata, K., et al. 1991. Biochem. Biophys. Res. Commun. 177, 814.
See how others have used Sivelestat (CAS 127373-66-4). Click on the entry to view the PubMed entry .
PMID: # 29618653 Robinson, KM.|Ramanan, K.|Clay, ME.|McHugh, KJ.|Pilewski, MJ.|Nickolich, KL.|Corey, C.|Shiva, S.|Wang, J.|Muzumdar, R.|Alcorn, JF.| et al. 2018. JCI Insight. 3:
PMID: # 23155475 Gill, N. et al. 2012. PLoS ONE. 7: e49646.